Coronary Artery Disease and Diabetes Mellitus

被引:175
作者
Aronson, Doron [1 ]
Edelman, Elazer R. [2 ]
机构
[1] Technion Israel Inst Technol, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
[2] Harvard Univ, Brigham & Womens Hosp, MIT, Cardiovasc Div,Dept Med,Inst Med Sci & Engn,Med S, Boston, MA 02115 USA
关键词
Blood glucose; Coronary disease; Diabetes mellitus; Hypoglycemic agents; Revascularization; Statins; INTERNAL THORACIC ARTERY; ACUTE MYOCARDIAL-INFARCTION; ELUTING STENT IMPLANTATION; AMERICAN-HEART-ASSOCIATION; INTENSIVE GLYCEMIC CONTROL; GLUCAGON-LIKE PEPTIDE-1; BARE METAL STENTS; 5-YEAR FOLLOW-UP; CARDIOVASCULAR-DISEASE; BYPASS-SURGERY;
D O I
10.1016/j.ccl.2014.04.001
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Diabetes mellitus (DM) is a major risk factor for cardiovascular disease. Near-normal glycemic control does not reduce cardiovascular events. For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization procedure over optimal medical therapy. For multivessel coronary disease, randomized trials demonstrated the superiority of coronary artery bypass grafting over multivessel percutaneous coronary intervention in patients with treated DM. However, selection of the optimal myocardial revascularization strategy requires a multidisciplinary team approach ('heart team'). This review summarizes the current evidence regarding the effectiveness of various medical therapies and revascularization strategies in patients with DM.
引用
收藏
页码:439 / +
页数:18
相关论文
共 119 条
[1]
Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease - The bypass angioplasty revascularization investigation (BARI) [J].
Alderman, E ;
Bourassa, M ;
Brooks, MM ;
Califf, R ;
Chaitman, B ;
Detre, K ;
Faxon, DP ;
Feit, F ;
Frye, RL ;
Hardison, RM ;
Holmes, D ;
Holubkov, R ;
Kouchoukos, N ;
Krone, R ;
Rogers, W ;
Rosen, AD ;
Schaff, H ;
Schwartz, L ;
Siewers, AS ;
Sopko, G ;
SuttonTyrrell, K ;
Whitlow, P .
CIRCULATION, 1997, 96 (06) :1761-1769
[2]
Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[3]
[Anonymous], 2008, GUID IND DIAB MELL E
[4]
Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents The Acute Catheterization and Urgent Intervention Triage Strategy Trial [J].
Aoki, Jiro ;
Lansky, Alexandra J. ;
Mehran, Roxana ;
Moses, Jeffery ;
Bertrand, Michel E. ;
McLaurin, Brent T. ;
Cox, David A. ;
Lincoff, Michael ;
Ohman, E. Magnus ;
White, Harvey D. ;
Parise, Helen ;
Leon, Martin B. ;
Stone, Gregg W. .
CIRCULATION, 2009, 119 (05) :687-698
[5]
Coronary Artery Revascularization in Patients With Diabetes Mellitus [J].
Armstrong, Ehrin J. ;
Rutledge, John C. ;
Rogers, Jason H. .
CIRCULATION, 2013, 128 (15) :1675-1685
[6]
Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction [J].
Aronson, D ;
Rayfield, EJ ;
Chesebro, JH .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (04) :296-306
[7]
Potential mechanisms promoting restenosis in diabetic patients [J].
Aronson, D ;
Bloomgarden, Z ;
Rayfield, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (03) :528-535
[8]
Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus [J].
Aronson, Doron ;
Edelman, Elazer R. .
CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (02) :134-141
[9]
Revascularization for coronary artery disease in diabetes mellitus: Angioplasty, stents and coronary artery bypass grafting [J].
Aronson, Doron ;
Edelman, Elazer R. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2010, 11 (01) :75-86
[10]
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681